Expert Insights on Hepatocellular Carcinoma: A Comprehensive Guide

By Catherine Frenette MD FAST AGAF, in collaboration with Consulting Editor, Dr. Norman Gitlin, and Guest Editor Dr. Catherine Frenette, this issue provides current updates on Hepatocellular Carcinoma (HCC). It delves into the staging and treatment of HCC, addressing critical questions and offering the latest thoughts from experts in the field.

Global Epidemiology of Hepatocellular Carcinoma

The global epidemiology of HCC is changing, and understanding these shifts is crucial for prevention and treatment strategies. This section explores the evolving landscape of HCC epidemiology worldwide.

Prevention Strategies for HCC

Preventing HCC is a critical aspect of managing liver health. This article discusses various prevention strategies that can help reduce the risk of developing HCC.

Biomarkers or Biopsy for Diagnosis of HCC

Diagnosing HCC accurately is vital for effective treatment. This section compares the use of biomarkers and biopsy for diagnosing HCC, highlighting their advantages and limitations.

Screening and Surveillance Strategies

Screening and surveillance are essential for early detection and treatment of HCC. This article outlines the most effective strategies for improving the chances of success in HCC management.

Imaging Diagnosis of HCC

Imaging plays a crucial role in diagnosing HCC. This section discusses the various imaging modalities used for diagnosing HCC and their respective merits.

Surgical Resection: Old Dog–Any New Tricks

Surgical resection remains a cornerstone in the treatment of HCC. This article explores whether there are any new techniques or advancements in surgical resection for HCC.

Hepatocellular Carcinoma and Liver Transplant

Liver transplant is a viable option for some HCC patients. This section discusses how changes in organ allocation may affect HCC patients within transplant criteria.

Downstaging to Liver Transplant: Choosing the Right Patient

Downstaging HCC patients to liver transplant requires careful patient selection. This article outlines the criteria for selecting the right patient for this treatment approach.

Locoregional Therapies for Hepatocellular Carcinoma

Locoregional therapies have evolved significantly over the past decade. This section reviews these changes and their implications for HCC treatment.

External Beam Radiotherapy: A Place in HCC Treatment

External beam radiotherapy is an emerging treatment option for HCC. This article examines its potential role in the management of HCC.

Tyrosine Kinase Inhibitors and Hepatocellular Carcinoma

Tyrosine kinase inhibitors have shown promise in treating HCC. This section delves into their mechanism of action and efficacy in HCC treatment.

Immuno-oncology for Hepatocellular Carcinoma

Immuno-oncology is a rapidly evolving field with potential applications in HCC treatment. This article discusses the present and future of immuno-oncology in managing HCC.

Managing Side Effects of Systemic Therapies for HCC

Systemic therapies for HCC can have significant side effects. This section provides a guide for hepatologists on managing these side effects effectively.

Why a Multi-disciplinary Tumor Board is Critical for Success

A multi-disciplinary tumor board is essential for achieving success in managing HCC patients. This article highlights the importance of a collaborative approach in HCC treatment.

This comprehensive guide aims to provide readers with the necessary information to improve patient outcomes in HCC. It covers the latest developments in staging, treatment, and management strategies, making it an invaluable resource for healthcare professionals and researchers alike.